EV/EBITDA:
-17.95-0.40(-2.28%)Summary
- As of today (July 5, 2025), MLTX EV/EBITDA is -17.95, with a fall of -0.40 (-2.28%) during the most recent trading session on July 3, 2025.
- Over the past year, MLTX EV/EBITDA has increased by +11.58 (+39.21%).
- MLTX EV/EBITDA is now -606.69% below its all-time high of -2.54.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.3% | +2.3% | +2.1% |
| 1 m1 month | -0.7% | +0.8% | +0.7% |
| 3 m3 months | -30.9% | +31.0% | +28.5% |
| 6 m6 months | +20.3% | -8.9% | -8.5% |
| ytdytd | +21.4% | -10.2% | -9.7% |
| 1 y1 year | +39.2% | +25.6% | +15.8% |
| 5 y5 years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -15.60 | -15.1% | -18.80 | +4.5% |
| 3 m | 3-month | -11.66 | -54.0% | -18.80 | +4.5% |
| 6 m | 6-month | -11.66 | -54.0% | -22.53 | +20.3% |
| 1 y | 1-year | -11.66 | -54.0% | -40.25 | +55.4% |
| 3 y | 3-year | -2.54 | -606.7% | -63.12 | +71.6% |
| 5 y | 5-year | -2.54 | -606.7% | -63.12 | +71.6% |
| alltime | all time | -2.54 | -606.7% | -63.12 | +71.6% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -17.95(-21.4%) |
| 2024 | -22.84(-61.4%) |
| Date | Value |
|---|---|
| 2023 | -59.22(+895.3%) |
| 2022 | -5.95 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -17.95
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +4.89 (+21.41%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +11.58 (+39.21%)